Crescentic glomerulonephritis due to rifampin treatment in a patient with pulmonary atypical mycobacteriosis

Hisanobu Ogata

研究成果: Contribution to journalArticle査読

16 被引用数 (Scopus)

抄録

A 64-year-old male was treated continuously with rifampin, isoniazid and streptomycin for pulmonary atypical mycobacteriosis, Mycobacterium kansasii. Five weeks after beginning the treatment, the patient suddenly developed acute renal failure. A renal biopsy showed crescentic lesions characteristic of rapidly progressive glomerulonephritis with moderate interstitial changes. Serum antirifampin antibody was detected, and the cessation of rifampin treatment was followed by a rapid spontaneous recovery of the patient's renal function. This is, to our knowledge, the first case of rapidly progressive crescentic glomerulonephritis associated with rifampin treatment where circulating antirifampin antibody is demonstrated and the renal function spontaneously improved after discontinuing rifampin treatment.

本文言語英語
ページ(範囲)319-322
ページ数4
ジャーナルNephron
78
3
DOI
出版ステータス出版済み - 3 19 1998

All Science Journal Classification (ASJC) codes

  • Physiology
  • Nephrology
  • Physiology (medical)
  • Urology

フィンガープリント 「Crescentic glomerulonephritis due to rifampin treatment in a patient with pulmonary atypical mycobacteriosis」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル